Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Case–control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis
Anna Gillio‐Tos, Maria da Graça Bicalho, Valentina Fiano, et al.
BMC Cancer (2012) Vol. 12, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
HLA-G Molecules in Autoimmune Diseases and Infections
Roberta Rizzo, Daria Bortolotti, Silvia Bolzani, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 111
Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis
Verônica Colpani, Frederico Soares Falcetta, Augusto Bacelo Bidinotto, et al.
PLoS ONE (2020) Vol. 15, Iss. 2, pp. e0229154-e0229154
Open Access | Times Cited: 101
HLA‐G: Function, polymorphisms and pathology
Antonio Arnaiz‐Villena, Ignacio Juárez, Fabio Suárez‐Trujillo, et al.
International Journal of Immunogenetics (2020) Vol. 48, Iss. 2, pp. 172-192
Open Access | Times Cited: 49
Role of HLA-G in Viral Infections
Simon Jasinski‐Bergner, Dominik Schmiedel, Ofer Mandelboim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: A candidate molecule for therapeutic intervention and prognostic biomarker?
Fabrícia Gimenes, Jorge Juarez Vieira Teixeira, André Luelsdorf Pimenta de Abreu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2014) Vol. 1846, Iss. 2, pp. 576-589
Closed Access | Times Cited: 35
The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis
Huihui Xu, Wei‐Hua Yan, Aifen Lin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 28
Role of HLA-G in tumors and upon COVID-19 infection
Barbara Seliger
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110792-110792
Open Access | Times Cited: 3
The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec
Stephanie Metcalfe, Michel Roger, Marie-Claude Faucher, et al.
Human Immunology (2013) Vol. 74, Iss. 12, pp. 1610-1615
Closed Access | Times Cited: 36
HLA‐G 3′ untranslated region polymorphisms influence the susceptibility for human papillomavirus infection
Heping Xu, Weiwu Shi, Aifen Lin, et al.
Tissue Antigens (2014) Vol. 84, Iss. 2, pp. 216-222
Open Access | Times Cited: 21
The analysis of human leukocyte antigen‐G level in patients with endometrial cancer by Western blot technique
Małgorzata Walentowicz‐Sadlecka, Konrad Dziobek, Marek Grabiec, et al.
American Journal of Reproductive Immunology (2018) Vol. 81, Iss. 1
Closed Access | Times Cited: 20
Greater expression of the human leukocyte antigen-G (HLA-G) and interleukin-17 (IL-17) in cervical intraepithelial neoplasia: analytical cross-sectional study
Lidyane Neves Miranda, Fernanda Priscila Santos Reginaldo, Daliana Maria Berenice Oliveira Souza, et al.
Sao Paulo Medical Journal (2014) Vol. 133, Iss. 4, pp. 336-342
Open Access | Times Cited: 19
Physiopathology and effectiveness of therapeutic vaccines against human papillomavirus
Ayesha Noor, Sara Aboulaghras, Muhammad Jahangeer, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 35, pp. 47752-47772
Open Access | Times Cited: 11
HLA-G - evolvement from a trophoblast specific marker to a checkpoint molecule in cancer, a narrative review about the specific role in breast- and gynecological cancer
Julia Knabl, Ye Yao, Gernot Desoyé, et al.
Journal of Reproductive Immunology (2024) Vol. 166, pp. 104385-104385
Open Access | Times Cited: 1
Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women
Valentina Fiano, Morena Trevisan, Francesca Fasanelli, et al.
Gynecologic Oncology (2018) Vol. 151, Iss. 2, pp. 319-326
Open Access | Times Cited: 12
A pilot study on Hla-G locus control region haplotypes and cervical intraepithelial neoplasias
Juliana Cochesnki Cordeiro, José Samuel da Silva, Valéria Sperandio Roxo, et al.
Human Immunology (2016) Vol. 78, Iss. 3, pp. 281-286
Closed Access | Times Cited: 4
Inside the pocket: Critical elements of HLA‐mediated susceptibility to cervical precancerous lesions
Letícia Boslooper Gonçalves, Patrícia Pinho de França, Natália Angelica Petry, et al.
HLA (2021) Vol. 98, Iss. 5, pp. 448-458
Closed Access | Times Cited: 1
Greater expression of the human leukocyte antigen-G (HLA-G) and interleukin-17 (IL-17) in cervical intraepithelial neoplasia: analytical cross-sectional study Aumento da expressão do antígeno leucocitário humano-G (HLA-G) e interleucina-17 (IL-17) em neoplasia intraepitelial cervical: estudo transversal analítico
Fernanda Priscila, Maria Berenice, Oliveira Souza, et al.
(2015)
Closed Access
Page 1

Scroll to top